Skip to content
Screener

Enpro NPO Food and biopharmaceutical — Net Sales

Other product segments

Semiconductors
$97M+15.9%
General industrial
$85.9M+16.7%
Commercial vehicle
$37M-8.0%
Aerospace
$22.5M-7.8%
Food and pharmaceutical
$22.4M+24.4%
Power generation
$20.4M+17.2%
Oil and gas
$17.8M+11.9%

Similar metrics at other companies

The J.M. Smucker Company logo
SJMCat food — Net Sales
$195M+7.3%
POS
POSTPet Food — Net Sales
$318.8M-12.6%
Target logo
TGTFood And Beverage — Net Sales
$6.26B+6.1%
The J.M. Smucker Company logo
SJMU.S.Retail Pet Foods — Net Sales
$417.1M-1.4%
Floor & Decor logo
FNDWood — Net Sales
$83.33M+1.0%
SharkNinja logo
SNFood Preparation Appliances — Net Sales
$458.61M+13.3%

Other financials

Income statement

See full
Revenue$303.0M+10.9%
Gross profit$130.0M+10.0%
Operating income$43.5M+4.1%
Net income$27.4M+11.8%
EPS (diluted)$1.29+12.2%

Balance sheet

See full
Cash & equivalents$79.2M-67.0%
Total debt$617.8M-4.5%
Total equity$1.6B+6.9%
Total assets$2.6B+5.1%

Cash flow

See full
Operating cash flow$39.6M+88.6%
CapEx$12.2M+52.5%
Free cash flow$27.4M+111%

Valuation

See full
Market cap$6.95B+50.8%
Enterprise value$7.49B+50.4%
P/E69.6×
P/S5.9×+1.7×

Profitability

See full
Gross margin42.6%-0.4pp
Operating margin13.9%-0.7pp
Net margin7.8%
FCF margin14.8%+0.8pp

Returns & leverage

See full
Return on equity5.8%
Debt / equity0.4×0.0×
Current ratio2.2×-0.7×

Where this comes from

Reported directly by Enpro in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The source filing: Enpro’s 10-K, filed February 19, 2026.

Filed
Feb 19, 2026, 4:30 PM EST
Fiscal year
FY2025
Accession
0001628280-26-009798
Line itemSealing TechnologiesAdvanced Surface TechnologiesTotal
Aerospace$75.6$17.3$92.9
Commercial vehicle168.1168.1
Food and biopharmaceutical76.376.3
General industrial272.526.9299.4
Oil and gas60.67.668.2
Power generation71.371.3
Semiconductors7.9359.2367.1
Total third-party sales$732.3$411.0$1,143.3

ITEM 16. FORM 10-K SUMMARY

FAQ

What is Enpro's food and biopharmaceutical — net sales?
Enpro (NPO) reported food and biopharmaceutical — net sales of $19.08M in Q4 2025.
How has Enpro's food and biopharmaceutical — net sales changed year-over-year?
Enpro's food and biopharmaceutical — net sales increased by 12.7% year-over-year, from $16.93M to $19.08M.
What is the long-term trend for Enpro's food and biopharmaceutical — net sales?
Over 2 years (2023 to 2025), Enpro's food and biopharmaceutical — net sales has grown at a 8.0% compound annual growth rate (CAGR), from $65.4M to $76.3M.
What does food and biopharmaceutical — net sales mean?
This metric represents the total revenue generated from the sale of goods and services specifically within the food and biopharmaceutical market segment. It reflects the company's ability to monetize its specialized industrial and processing solutions tailored to the stringent regulatory and quality requirements of these industries. Monitoring this figure helps assess the segment's market penetration and its contribution to the overall corporate top-line growth.

Ask your AI about Enpro's food and biopharmaceutical — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude